ESN Cleer is an innovative medical solutions company established in 2018, pioneering a novel approach to one of the most significant health problems affecting the world. ESN Cleer incorporates the latest science and technology developments to develop its solutions, producing highly accurate preventative solutions accessible to the mass population. The application of nanotechnology, synthetic protein synthesis and sophisticated analytical software coupled with clinical evidence has enabled a highly precise and rapid assay that, until now, was impossible to create.

 

Our Mission is to lower the incidence of fatal heart failure by providing B2B solutions to identify asymptomatic, high-risk Heart Failure patients early.

​

The ESN Cleer solutions will remove time and cost barriers from detecting asymptomatic early risks of developing heart failure. Heart failure risk identification will enable effective prevention and dramatically minimise the disease's economic, emotional and social burden and significantly impact the mass population.